Ideaya Biosciences (IDYA) PT Lowered to $63 at Truist Securities

July 7, 2026 7:09 AM

Truist Securities analyst Greg Renza lowered the price target on Ideaya Biosciences (NASDAQ: IDYA) to $63.00 (from $65.00) while maintaining a Buy rating.

No results found